Antifibrotic compounds and related methods
US12180188B2 · kind B2 · utility
0Cited by
5References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 22, 2022 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | Nov 22, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This discloses that compounds of Formula 1 have antifibrotic properties. In particular, this discloses a pharmaceutical composition including one or more compounds of Formula 1 and methods of using compounds of Formula 1 in fibrosis treatment and inhibiting type 1 collagen synthesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.